{
    "clinical_study": {
        "@rank": "4904", 
        "brief_summary": {
            "textblock": "It is to be achieved that in postmenopausal women through the combination of Hysteroscopy\n      and intraoperative rapid section a positive predictive value (PPV) regarding the objective\n      illness like endometrial cancer or adenomatous hyperplasia of 100% so as a negative\n      predictive value (NPV) of 99%."
        }, 
        "brief_title": "OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Endometrial Cancer", 
            "Atypical Hyperplasia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Endometrial Neoplasms", 
                "Endometrial Hyperplasia", 
                "Hyperplasia"
            ]
        }, 
        "detailed_description": {
            "textblock": "If a patient fulfills the inclusion criteria, the surgeon decides intraoperatively due to\n      the aspect in the hysteroscopy if it is a clearly benign result or if it looks suspicious or\n      malign.\n\n      In case of a hysteroscopical benign result the patient will be informed about the result\n      after the operation.\n\n      In case of a hysteroscopal suspicious or malignant aspect, the curettement will be sent for\n      a rapid section. If the hysteroscopic result confirms the hysteroscopic suspicion the\n      patient will be informed after the operation and the further treatment can be planned right\n      away."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Postmenopausal status (more than 1 year of last menopausal bleeding)\n\n          -  Postmenopausal vaginal bleeding\n\n          -  Asymptomatic postmenopausal endometrial hyperplasia\n\n          -  Understanding of the german language\n\n          -  Signature and consent of the patient\n\n        Exclusion Criteria:\n\n          -  Not able to understand and participate in the study\n\n          -  Premenopausal status\n\n          -  no informed consent"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "45 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Postmenopausal women"
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01961102", 
            "org_study_id": "BHS-Gyn1"
        }, 
        "intervention": {
            "intervention_name": "hysteroscopy/curettage in case of suspicious aspect will be done a rapid section", 
            "intervention_type": "Procedure", 
            "other_name": "OSCAR Endo Study"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "postmenopausal bleeding", 
            "postmenopausal hyperplasia", 
            "endometrial cancer", 
            "atypical hyperplasia", 
            "curettage", 
            "intraoperative rapid section"
        ], 
        "lastchanged_date": "January 21, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Linz", 
                    "country": "Austria", 
                    "zip": "4020"
                }, 
                "name": "Department of Gynaecology, Barmherzige Schwestern"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_groups": "1", 
        "official_title": "Pilot-study of OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer", 
        "overall_contact": {
            "email": "lukas.hefler@bhs.at", 
            "last_name": "Lukas Hefler, Univ.-Doz.", 
            "phone": "0043 732 7677", 
            "phone_ext": "7160"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Austria: Ethikkommission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To get in combination of hysteroscopy and rapid section of the endometrial curettement a negative predictive value of 99% as well as a positive predictive value of 100%.", 
            "measure": "A negative predictive value of 99 %", 
            "safety_issue": "No", 
            "time_frame": "Intraoperative"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01961102"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Krankenhaus Barmherzige Schwestern Linz", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Krankenhaus Barmherzige Schwestern Linz", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Case-Only", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}